APA
Medina J., Picarles V., Greiner B., Elsaesser C., Kolopp M., Mahl A., Roman D., Vogel B., Nussbaumer P., Winiski A., Meingassner J. & Fraissinette A. d. B. d. (20031219). LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis. : Biochemical pharmacology.
Chicago
Medina Jesús, Picarles Valérie, Greiner Brigitte, Elsaesser Christian, Kolopp Maryelle, Mahl Andreas, Roman Danielle, Vogel Beate, Nussbaumer Peter, Winiski Anthony, Meingassner Josef and Fraissinette Anne de Brugerolle de. 20031219. LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis. : Biochemical pharmacology.
Harvard
Medina J., Picarles V., Greiner B., Elsaesser C., Kolopp M., Mahl A., Roman D., Vogel B., Nussbaumer P., Winiski A., Meingassner J. and Fraissinette A. d. B. d. (20031219). LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis. : Biochemical pharmacology.
MLA
Medina Jesús, Picarles Valérie, Greiner Brigitte, Elsaesser Christian, Kolopp Maryelle, Mahl Andreas, Roman Danielle, Vogel Beate, Nussbaumer Peter, Winiski Anthony, Meingassner Josef and Fraissinette Anne de Brugerolle de. LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis. : Biochemical pharmacology. 20031219.